ExodusPoint Capital Management »

Applied Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $413k 61k 6.79

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Meta Platforms Cl A (META)
Global Payments (GPN)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NiSource (NI)
PPL Corporation (PPL)
Intel Corporation (INTC)
Marvell Technology (MRVL)
Exxon Mobil Corporation (XOM)

View all positions for ExodusPoint Capital Management

Top funds holding Applied Therapeutics

Franklin Resources
VR Adviser
Perceptive Advisors
Henderson Group
Propel Bio Management
Knoll Capital Management
Alyeska Investment Group
Morgan Stanley
Vanguard Group
Simplify Asset Management
Adage Capital Partners GP
Tang Capital Management
Frazier Life Sciences Management
Parkman Healthcare Partners
Schonfeld Strategic Advisors

View all funds holding Applied Therapeutics